June 19, 2012

Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes

- Research collaboration with affiliate of Harvard Medical School aims to develop novel therapeutic approaches -

 

Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
- Research collaboration with affiliate of Harvard Medical School aims to develop novel therapeutic approaches -

Paris, France – June 19, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) and the Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, today announced a new collaboration to promote the development of new medicines for the treatment of diabetes and related disorders. The collaboration was unveiled at the 2012 Bio International Convention in Boston, Mass.